Literature DB >> 2925563

Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

K Yamada1, K Akiyoshi, H Murakami, T Sugahara, I Ikeda, K Toyoda, H Omura.   

Abstract

We screened for immunoglobulin (Ig) production stimulating factor (IPSF) which enhanced Ig production of human-to-human hybridomas in serum-free culture, and found that culture supernatant and lysate of human lymphoblastoid Namalwa cells stimulated proliferation and Ig production of human-to-human hybridoma HB4C5 cells. The IPSF in Namalwa lysate was partially purified with DEAE-Toyopearl 650M, hydroxylapatite and Superose 6HR 10/30 column chromatographies. The partially purified IPSF was a macromolecule of about 500,000 dalton containing 72,000 dalton protein as a major component. The activity was stable at pH 6 to 12, but inactivated partially by heating over 40 degrees C (60% decrease) and completely by trypsin digestion. These results suggest that the IPSF activity is due to its protein and heat-stable components. The Namalwa IPSF stimulated proliferation of human-to-human hybridomas but not that of mouse-to-mouse hybridomas. The IPSF also stimulated Ig production of human-to-human hybridomas derived from NAT-30 cells, but not that of other human-to-human or mouse-to-mouse hybridomas. NAT-30 is a human fusion partner derived from Namalwa cells. These results suggest that the Namalwa IPSF is an autocrine factor that stimulates proliferation and Ig production of hybridomas derived from NAT-30 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2925563     DOI: 10.1007/BF02628461

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  19 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Characterization of monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; A K Ng; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

3.  Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

4.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

6.  Immunoglobulin production stimulating and inhibiting factors derived from human lung adenocarcinoma PC-8 cells : Ig production stimulating factor in PC-8 cells.

Authors:  H Shinmoto; H Murakami; K Yamada; S Dosako; H Omura
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

7.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

8.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

9.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.

Authors:  J Gordon; S C Ley; M D Melamed; P Aman; N C Hughes-Jones
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more
  12 in total

1.  Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.

Authors:  T Sugahara; S Shirahata; K Yamada; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

2.  Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells.

Authors:  T Sugahara; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 3.  Physiological enhancement of immunoglobulin production of hybridomas in serum-free media.

Authors:  H Murakami; K Yamada; S Shirahata; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

Review 4.  What should be focused in the study of cell culture technology for production of bioactive proteins.

Authors:  H Murakami
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

5.  Stimulation of proliferation and immunoglobulin production of human-human hybridoma by various types of caseins and their protease digests.

Authors:  K Yamada; I Ikeda; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

6.  Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.

Authors:  M Yamaguchi; Y Shirai; Y Inouye; M Shoji; M Kamei; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

7.  Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody.

Authors:  H Tachibana; K Taniguchi; Y Ushio; K Teruya; K Osada; H Murakami
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

8.  Purification and characterization of immunoglobulin production stimulating factor derived from human B lymphoblastoid HO-323 cells.

Authors:  K Toyoda; T Sugahara; K Inouye; K Yamada; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

9.  Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions.

Authors:  K Yamada; I Ikeda; T Sugahara; S Hashizume; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

10.  Immunoglobulin production stimulating factor-II alpha (IPSF-II alpha) is glyceraldehyde-3-phosphate dehydrogenase like protein.

Authors:  T Sugahara; S Shirahata; K Akiyoshi; T Isobe; T Okuyama; H Murakami
Journal:  Cytotechnology       Date:  1991-06       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.